TRIAD trademark TM76429838 registered for loudspeakers

The USPTO registered trademark TM76429838 for the word mark "TRIAD" in International Class 9 (loudspeakers) on April 2, 2026. The application was originally filed on July 10, 2002. This registration establishes exclusive trademark rights for the holder in connection with the specified goods in the United States.

System and method for implantable muscle interface

The USPTO granted Patent US12594172B2 to Johns Hopkins University for an implantable human-machine interfacing system that captures electromyographic signals from muscles and provides sensory feedback through electrical stimulation. The system includes sensors, amplifiers, a transceiver for wireless transmission to an external decoder, and an implantable power source for neuromodulation. The patent covers applications in prosthetics and assistive devices.

Robotic system for shoulder arthroplasty using stemless implant components

USPTO granted patent US12594171B2 to Howmedica Osteonics Corp. covering robotic systems and methods for shoulder arthroplasty. The patent describes a guidance station that tracks surgical tools, patient humerus, and scapula to control tool movement relative to virtual cutting boundaries for bone preparation. The system positions implants based on bone density characteristics.

Glaucoma Shunts and Related Methods of Use - US12594187B2

USPTO granted patent US12594187B2 to Hexiris Inc. for glaucoma shunts and associated methods of use. The patent covers elongate bodies with inner walls defining lumens for draining aqueous humour to decrease intraocular pressure in eyes. The patent contains 8 claims and is classified under CPC codes A61F 9/00781 and related ophthalmic categories.

Prosthesis for Lung and Treatment Method for Pulmonary Fibrosis

The USPTO granted Patent US12594156B2 to National Institute of Biological Sciences, Beijing for a lung prosthesis designed to treat pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF). The patent covers 16 claims and was filed on May 30, 2019. This grant confers exclusive intellectual property rights to the assignee for the prosthetic device and associated treatment methods.

Hybrid braided stent, US12594154B2, 7th Apr

Hybrid braided stent, US12594154B2, 7th Apr

Expandable interbody spinal prosthesis

USPTO granted patent US12594169B2 to MiRus LLC for an expandable interbody device used as a prosthesis during spinal surgery. The device includes a drive block, linkage block, drive screw, first and second endplates, and linkages configured to provide spinal stability. The patent contains 30 claims.

Hernia repair, breast reconstruction and sling devices containing poly(butylene succinate)

USPTO granted patent US12594361B2 to Tepha, Inc. on April 7, 2026, covering resorbable implants made from poly(butylene succinate) and copolymers for hernia repair, breast reconstruction, and sling devices. The patent includes 17 claims and covers sterilized devices with specific endotoxin requirements, oriented fibers, meshes, and 3D-printed forms. The technology also includes receptacles for cardiac rhythm management devices such as pacemakers and neurostimulators.

Orthotic and Prosthetic Device and Manufacturing System and Method

USPTO granted patent US12594173B2 to Hanger, Inc. for an orthotic and prosthetic device including a socket, fasteners, and pylon system. The patent covers the mechanical coupling design between socket components and pylon through threaded fasteners extending through aligned through-holes and blind-holes. This patent affects medical device manufacturers developing prosthetic limbs.

Vasopressin-2 receptor antagonist peptides and uses thereof

The USPTO has granted Patent US12595288B2 to Commissariat à l'Énergie Atomique et aux Énergies Alternatives covering vasopressin-2 receptor antagonist peptides. The patent protects peptide sequences with at least 80% amino acid identity to SEQ ID NO. 1, with specific modifications at variable positions enabling therapeutic applications. The grant includes 14 claims.